We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s disease (CD) (including associated symptoms such as abdominal cramps, reduced appetite, diarrhea, frequent fevers and/or liver disease), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
